5.35
Finanzdaten der Bioage Labs Inc-Aktie (BIOA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
11.58%
2.451
|
2.772 | 3.078 | 2.054 | 2.412 |
| Operating Expenses |
12.92%
31.78
|
28.15 | 31.50 | 25.19 | 27.18 |
| Operating Income/Loss |
15.60%
-29.33
|
-25.38 | -28.42 | -23.14 | -24.77 |
| Nonoperating Income/Loss |
3.65%
3.236
|
3.122 | 2.48 | 2.969 | 3.208 |
| Net Income/Loss |
17.27%
-26.10
|
-22.25 | -25.94 | -20.17 | -21.56 |
| Basic Average Shares |
5.55%
44.84
|
42.48 | - | 35.85 | 35.85 |
| Diluted Average Shares |
5.55%
44.84
|
42.48 | - | 35.85 | 35.85 |
| Basic Earnings Per Share |
11.54%
-0.58
|
-0.52 | - | -0.56 | -0.60 |
| Diluted Earnings Per Share |
11.54%
-0.58
|
-0.52 | - | -0.56 | -0.60 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):